Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 440
Selected: 0
NCT IDTitle
NCT06427369An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
NCT04635761Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening
NCT03727061Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer
NCT00053118Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer
NCT05423340Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems
NCT07082270Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT06350500A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
NCT03895918Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients
NCT00736645Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00023985Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
NCT01971489Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT03727789CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
NCT02853318Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02534376Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal
NCT00244998Fulvestrant in Treating Patients With Advanced Prostate Cancer
NCT07039630A Food Security Intervention for the Prevention of Cancer in Low-income Families
NCT01982487Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission
NCT04484532Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
NCT06733363A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
NCT06202066Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
NCT00033566S-3304 in Treating Patients With Advanced Solid Tumors
NCT00002975Photodynamic Therapy in Treating Patients With Skin Cancer
NCT04548193Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship
NCT00003898Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
NCT00559481Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
NCT00835900An Alternative Dosing Schedule of Varenicline for Smoking Cessation
NCT01536067Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
NCT03011736Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism
NCT02474095Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
NCT02501031Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women
NCT00856388Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
NCT02982720Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
NCT06821997NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial
NCT06563388Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
NCT00030550Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
NCT01326481Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
NCT02713373Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
NCT00054522Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
NCT00054002Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
NCT01833208Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
NCT06306638Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
NCT05518032Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)
NCT00002578Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
NCT01558778Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
NCT00002964Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
NCT03925532Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant
NCT00736164Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer
NCT00084721Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
NCT01769885Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer
NCT01582009Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate